BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Staging
11 results:

  • 1. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
    Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
    Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
    Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer.
    He M; Wang Y; Zhang G; Cao K; Yang M; Liu H
    J Gynecol Oncol; 2021 May; 32(3):e32. PubMed ID: 33825354
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. UBE2C Drives Human Cervical cancer Progression and Is Positively Modulated by mTOR.
    Chiang AJ; Li CJ; Tsui KH; Chang C; Chang YI; Chen LW; Chang TH; Sheu JJ
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396624
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Human papilloma virus (HPV) integration signature in Cervical cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Kamal M; Lameiras S; Deloger M; Morel A; Vacher S; Lecerf C; Dupain C; Jeannot E; Girard E; Baulande S; Dubot C; Kenter G; Jordanova ES; Berns EMJJ; Bataillon G; Popovic M; Rouzier R; Cacheux W; Le Tourneau C; Nicolas A; Servant N; Scholl SM; Bièche I;
    Br J Cancer; 2021 Feb; 124(4):777-785. PubMed ID: 33191407
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High risk endometrial cancer: Clues towards a revision of the therapeutic paradigm.
    Bendifallah S; Ilenko A; Daraï E
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):863-871. PubMed ID: 31176047
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Imaging and staging of neuroendocrine cervical cancer.
    Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P
    Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.
    Black JD; English DP; Roque DM; Santin AD
    Womens Health (Lond); 2014 Jan; 10(1):45-57. PubMed ID: 24328598
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular alterations in uterine serous carcinoma.
    Hayes MP; Ellenson LH
    Gynecol Oncol; 2010 Feb; 116(2):286-9. PubMed ID: 20109727
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular alterations of EGFR and pik3ca in uterine serous carcinoma.
    Hayes MP; Douglas W; Ellenson LH
    Gynecol Oncol; 2009 Jun; 113(3):370-3. PubMed ID: 19272638
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pik3ca gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by pik3ca pseudogene sequences.
    Miyake T; Yoshino K; Enomoto T; Takata T; Ugaki H; Kim A; Fujiwara K; Miyatake T; Fujita M; Kimura T
    Cancer Lett; 2008 Mar; 261(1):120-6. PubMed ID: 18180098
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.